ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Roxithromycin Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28E14376
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Roxithromycin Tablets Market Research Report 2023
BUY CHAPTERS

Global Roxithromycin Tablets Market Research Report 2025

Code: QYRE-Auto-28E14376
Report
May 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi-Aventis Deutschland GmbH
Shanghai Shyndec Pharmaceutical Co.,Ltd
Sichuan Kelun Pharmaceutical Co., Ltd.
Chongqing Kerui Pharmaceutical(Group)Co.,Ltd.
Zhejiang Zhenyuan Pharmaceutical Co. Ltd
CSPC Ouyi Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc
Suzhou Dawnrays Pharmaceutical Co., Ltd.
Zhuhai Tongyuan Pharmaceutical Co., Ltd.
Guilin Pharmaceutical Co., Ltd
Jilin Jingxin Pharmaceutical Group Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Tianjin Meihua Pharmaceutical Co., Ltd.
Guangzhou Pui's Pharmaceutical Factory Ltd.
Beijing Chunfeng Pharmaceutical Co., Ltd.
JiLin Daojun Pharmaceutical Co., Ltd.
Liaoning Yifan Pharmaceutical Co., Ltd.
Merro Pharmaceutical Co.,Ltd.
Guangdong Piedy Pharmaceutical Co., Ltd.
Inner Mongolia Northeast LiuYao Group Co., Ltd.
Jiangxi Huiren Pharmaceutical Co., Ltd.
Jiangsu Pengyao Pharmaceuticals, Inc.
Shandong Luyin Pharmaceutical Co., Ltd.
Shaanxi Huaxi Pharmaceutical Co., Ltd.

Roxithromycin Tablets Market

The global market for Roxithromycin Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Roxithromycin is a macrolide antibiotic with broad-spectrum antibacterial activity. It is used to treat infections caused by pathogens susceptible to roxithromycin, such as ear, nose, and throat infections (tonsillitis, pharyngitis, sinusitis), respiratory tract infections (acute bronchitis, pneumonia), skin and soft tissue infections (impetigo ), genitourinary tract infection (nongonococcal urethritis), etc.
North American market for Roxithromycin Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Roxithromycin Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Roxithromycin Tablets include Sanofi-Aventis Deutschland GmbH, Shanghai Shyndec Pharmaceutical Co.,Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Jilin Jingxin Pharmaceutical Group Co., Ltd., Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Tianjin Meihua Pharmaceutical Co., Ltd., Guangzhou Pui's Pharmaceutical Factory Ltd., Beijing Chunfeng Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Roxithromycin Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roxithromycin Tablets.
The Roxithromycin Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Roxithromycin Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Roxithromycin Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Roxithromycin Tablets Market Report

Report Metric Details
Report Name Roxithromycin Tablets Market
Segment by Type
  • 50mg
  • 75mg
  • 150mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi-Aventis Deutschland GmbH, Shanghai Shyndec Pharmaceutical Co.,Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Jilin Jingxin Pharmaceutical Group Co., Ltd., Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Tianjin Meihua Pharmaceutical Co., Ltd., Guangzhou Pui's Pharmaceutical Factory Ltd., Beijing Chunfeng Pharmaceutical Co., Ltd., CSPC Ouyi Pharmaceutical Co.,Ltd., JiLin Daojun Pharmaceutical Co., Ltd., Liaoning Yifan Pharmaceutical Co., Ltd., Merro Pharmaceutical Co.,Ltd., Guangdong Piedy Pharmaceutical Co., Ltd., Inner Mongolia Northeast LiuYao Group Co., Ltd., Livzon Pharmaceutical Group Inc., Suzhou Dawnrays Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., Zhuhai Tongyuan Pharmaceutical Co., Ltd., Guilin Pharmaceutical Co., Ltd., Jiangsu Pengyao Pharmaceuticals, Inc., Shandong Luyin Pharmaceutical Co., Ltd., Shaanxi Huaxi Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Roxithromycin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Roxithromycin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Roxithromycin Tablets Market report?

Ans: The main players in the Roxithromycin Tablets Market are Sanofi-Aventis Deutschland GmbH, Shanghai Shyndec Pharmaceutical Co.,Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Jilin Jingxin Pharmaceutical Group Co., Ltd., Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Tianjin Meihua Pharmaceutical Co., Ltd., Guangzhou Pui's Pharmaceutical Factory Ltd., Beijing Chunfeng Pharmaceutical Co., Ltd., CSPC Ouyi Pharmaceutical Co.,Ltd., JiLin Daojun Pharmaceutical Co., Ltd., Liaoning Yifan Pharmaceutical Co., Ltd., Merro Pharmaceutical Co.,Ltd., Guangdong Piedy Pharmaceutical Co., Ltd., Inner Mongolia Northeast LiuYao Group Co., Ltd., Livzon Pharmaceutical Group Inc., Suzhou Dawnrays Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., Zhuhai Tongyuan Pharmaceutical Co., Ltd., Guilin Pharmaceutical Co., Ltd., Jiangsu Pengyao Pharmaceuticals, Inc., Shandong Luyin Pharmaceutical Co., Ltd., Shaanxi Huaxi Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Roxithromycin Tablets Market report?

Ans: The Applications covered in the Roxithromycin Tablets Market report are Hospital, Retail Pharmacy, Clinic, Others

What are the Type segmentation covered in the Roxithromycin Tablets Market report?

Ans: The Types covered in the Roxithromycin Tablets Market report are 50mg, 75mg, 150mg

Recommended Reports

Anti-Infective Drugs

Respiratory and Bronchitis

Antibiotics and APIs

1 Roxithromycin Tablets Market Overview
1.1 Product Definition
1.2 Roxithromycin Tablets by Type
1.2.1 Global Roxithromycin Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 75mg
1.2.4 150mg
1.3 Roxithromycin Tablets by Application
1.3.1 Global Roxithromycin Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Roxithromycin Tablets Market Size Estimates and Forecasts
1.4.1 Global Roxithromycin Tablets Revenue 2020-2031
1.4.2 Global Roxithromycin Tablets Sales 2020-2031
1.4.3 Global Roxithromycin Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Roxithromycin Tablets Market Competition by Manufacturers
2.1 Global Roxithromycin Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Roxithromycin Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Roxithromycin Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Roxithromycin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Roxithromycin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Roxithromycin Tablets, Product Type & Application
2.7 Global Key Manufacturers of Roxithromycin Tablets, Date of Enter into This Industry
2.8 Global Roxithromycin Tablets Market Competitive Situation and Trends
2.8.1 Global Roxithromycin Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Roxithromycin Tablets Players Market Share by Revenue
2.8.3 Global Roxithromycin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Roxithromycin Tablets Market Scenario by Region
3.1 Global Roxithromycin Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Roxithromycin Tablets Sales by Region: 2020-2031
3.2.1 Global Roxithromycin Tablets Sales by Region: 2020-2025
3.2.2 Global Roxithromycin Tablets Sales by Region: 2026-2031
3.3 Global Roxithromycin Tablets Revenue by Region: 2020-2031
3.3.1 Global Roxithromycin Tablets Revenue by Region: 2020-2025
3.3.2 Global Roxithromycin Tablets Revenue by Region: 2026-2031
3.4 North America Roxithromycin Tablets Market Facts & Figures by Country
3.4.1 North America Roxithromycin Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Roxithromycin Tablets Sales by Country (2020-2031)
3.4.3 North America Roxithromycin Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Roxithromycin Tablets Market Facts & Figures by Country
3.5.1 Europe Roxithromycin Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Roxithromycin Tablets Sales by Country (2020-2031)
3.5.3 Europe Roxithromycin Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Roxithromycin Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Roxithromycin Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Roxithromycin Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Roxithromycin Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Roxithromycin Tablets Market Facts & Figures by Country
3.7.1 Latin America Roxithromycin Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Roxithromycin Tablets Sales by Country (2020-2031)
3.7.3 Latin America Roxithromycin Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Roxithromycin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Roxithromycin Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Roxithromycin Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Roxithromycin Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Roxithromycin Tablets Sales by Type (2020-2031)
4.1.1 Global Roxithromycin Tablets Sales by Type (2020-2025)
4.1.2 Global Roxithromycin Tablets Sales by Type (2026-2031)
4.1.3 Global Roxithromycin Tablets Sales Market Share by Type (2020-2031)
4.2 Global Roxithromycin Tablets Revenue by Type (2020-2031)
4.2.1 Global Roxithromycin Tablets Revenue by Type (2020-2025)
4.2.2 Global Roxithromycin Tablets Revenue by Type (2026-2031)
4.2.3 Global Roxithromycin Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Roxithromycin Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Roxithromycin Tablets Sales by Application (2020-2031)
5.1.1 Global Roxithromycin Tablets Sales by Application (2020-2025)
5.1.2 Global Roxithromycin Tablets Sales by Application (2026-2031)
5.1.3 Global Roxithromycin Tablets Sales Market Share by Application (2020-2031)
5.2 Global Roxithromycin Tablets Revenue by Application (2020-2031)
5.2.1 Global Roxithromycin Tablets Revenue by Application (2020-2025)
5.2.2 Global Roxithromycin Tablets Revenue by Application (2026-2031)
5.2.3 Global Roxithromycin Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Roxithromycin Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi-Aventis Deutschland GmbH
6.1.1 Sanofi-Aventis Deutschland GmbH Company Information
6.1.2 Sanofi-Aventis Deutschland GmbH Description and Business Overview
6.1.3 Sanofi-Aventis Deutschland GmbH Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi-Aventis Deutschland GmbH Roxithromycin Tablets Product Portfolio
6.1.5 Sanofi-Aventis Deutschland GmbH Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical Co.,Ltd.
6.2.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.3.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
6.3.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.3.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product Portfolio
6.3.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
6.4.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
6.4.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.4.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Roxithromycin Tablets Product Portfolio
6.4.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.5 Jilin Jingxin Pharmaceutical Group Co., Ltd.
6.5.1 Jilin Jingxin Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Jilin Jingxin Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Jilin Jingxin Pharmaceutical Group Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jilin Jingxin Pharmaceutical Group Co., Ltd. Roxithromycin Tablets Product Portfolio
6.5.5 Jilin Jingxin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 Zhejiang Zhenyuan Pharmaceutical Co., Ltd.
6.6.1 Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Company Information
6.6.2 Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.6.5 Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Hainan Simcere Pharmaceutical Co., Ltd.
6.7.1 Hainan Simcere Pharmaceutical Co., Ltd. Company Information
6.7.2 Hainan Simcere Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Hainan Simcere Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hainan Simcere Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.7.5 Hainan Simcere Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Tianjin Meihua Pharmaceutical Co., Ltd.
6.8.1 Tianjin Meihua Pharmaceutical Co., Ltd. Company Information
6.8.2 Tianjin Meihua Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Tianjin Meihua Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tianjin Meihua Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.8.5 Tianjin Meihua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Guangzhou Pui's Pharmaceutical Factory Ltd.
6.9.1 Guangzhou Pui's Pharmaceutical Factory Ltd. Company Information
6.9.2 Guangzhou Pui's Pharmaceutical Factory Ltd. Description and Business Overview
6.9.3 Guangzhou Pui's Pharmaceutical Factory Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Guangzhou Pui's Pharmaceutical Factory Ltd. Roxithromycin Tablets Product Portfolio
6.9.5 Guangzhou Pui's Pharmaceutical Factory Ltd. Recent Developments/Updates
6.10 Beijing Chunfeng Pharmaceutical Co., Ltd.
6.10.1 Beijing Chunfeng Pharmaceutical Co., Ltd. Company Information
6.10.2 Beijing Chunfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Beijing Chunfeng Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Chunfeng Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.10.5 Beijing Chunfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 CSPC Ouyi Pharmaceutical Co.,Ltd.
6.11.1 CSPC Ouyi Pharmaceutical Co.,Ltd. Company Information
6.11.2 CSPC Ouyi Pharmaceutical Co.,Ltd. Description and Business Overview
6.11.3 CSPC Ouyi Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CSPC Ouyi Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product Portfolio
6.11.5 CSPC Ouyi Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.12 JiLin Daojun Pharmaceutical Co., Ltd.
6.12.1 JiLin Daojun Pharmaceutical Co., Ltd. Company Information
6.12.2 JiLin Daojun Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 JiLin Daojun Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 JiLin Daojun Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.12.5 JiLin Daojun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Liaoning Yifan Pharmaceutical Co., Ltd.
6.13.1 Liaoning Yifan Pharmaceutical Co., Ltd. Company Information
6.13.2 Liaoning Yifan Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Liaoning Yifan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Liaoning Yifan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.13.5 Liaoning Yifan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Merro Pharmaceutical Co.,Ltd.
6.14.1 Merro Pharmaceutical Co.,Ltd. Company Information
6.14.2 Merro Pharmaceutical Co.,Ltd. Description and Business Overview
6.14.3 Merro Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merro Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product Portfolio
6.14.5 Merro Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.15 Guangdong Piedy Pharmaceutical Co., Ltd.
6.15.1 Guangdong Piedy Pharmaceutical Co., Ltd. Company Information
6.15.2 Guangdong Piedy Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Guangdong Piedy Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Guangdong Piedy Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.15.5 Guangdong Piedy Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Inner Mongolia Northeast LiuYao Group Co., Ltd.
6.16.1 Inner Mongolia Northeast LiuYao Group Co., Ltd. Company Information
6.16.2 Inner Mongolia Northeast LiuYao Group Co., Ltd. Description and Business Overview
6.16.3 Inner Mongolia Northeast LiuYao Group Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Inner Mongolia Northeast LiuYao Group Co., Ltd. Roxithromycin Tablets Product Portfolio
6.16.5 Inner Mongolia Northeast LiuYao Group Co., Ltd. Recent Developments/Updates
6.17 Livzon Pharmaceutical Group Inc.
6.17.1 Livzon Pharmaceutical Group Inc. Company Information
6.17.2 Livzon Pharmaceutical Group Inc. Description and Business Overview
6.17.3 Livzon Pharmaceutical Group Inc. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Livzon Pharmaceutical Group Inc. Roxithromycin Tablets Product Portfolio
6.17.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
6.18 Suzhou Dawnrays Pharmaceutical Co., Ltd.
6.18.1 Suzhou Dawnrays Pharmaceutical Co., Ltd. Company Information
6.18.2 Suzhou Dawnrays Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Suzhou Dawnrays Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Suzhou Dawnrays Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.18.5 Suzhou Dawnrays Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Jiangxi Huiren Pharmaceutical Co., Ltd.
6.19.1 Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
6.19.2 Jiangxi Huiren Pharmaceutical Co., Ltd. Description and Business Overview
6.19.3 Jiangxi Huiren Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangxi Huiren Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.19.5 Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Zhuhai Tongyuan Pharmaceutical Co., Ltd.
6.20.1 Zhuhai Tongyuan Pharmaceutical Co., Ltd. Company Information
6.20.2 Zhuhai Tongyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Zhuhai Tongyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Zhuhai Tongyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.20.5 Zhuhai Tongyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.21 Guilin Pharmaceutical Co., Ltd.
6.21.1 Guilin Pharmaceutical Co., Ltd. Company Information
6.21.2 Guilin Pharmaceutical Co., Ltd. Description and Business Overview
6.21.3 Guilin Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Guilin Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.21.5 Guilin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.22 Jiangsu Pengyao Pharmaceuticals, Inc.
6.22.1 Jiangsu Pengyao Pharmaceuticals, Inc. Company Information
6.22.2 Jiangsu Pengyao Pharmaceuticals, Inc. Description and Business Overview
6.22.3 Jiangsu Pengyao Pharmaceuticals, Inc. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Jiangsu Pengyao Pharmaceuticals, Inc. Roxithromycin Tablets Product Portfolio
6.22.5 Jiangsu Pengyao Pharmaceuticals, Inc. Recent Developments/Updates
6.23 Shandong Luyin Pharmaceutical Co., Ltd.
6.23.1 Shandong Luyin Pharmaceutical Co., Ltd. Company Information
6.23.2 Shandong Luyin Pharmaceutical Co., Ltd. Description and Business Overview
6.23.3 Shandong Luyin Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Shandong Luyin Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.23.5 Shandong Luyin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.24 Shaanxi Huaxi Pharmaceutical Co., Ltd.
6.24.1 Shaanxi Huaxi Pharmaceutical Co., Ltd. Company Information
6.24.2 Shaanxi Huaxi Pharmaceutical Co., Ltd. Description and Business Overview
6.24.3 Shaanxi Huaxi Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Shaanxi Huaxi Pharmaceutical Co., Ltd. Roxithromycin Tablets Product Portfolio
6.24.5 Shaanxi Huaxi Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Roxithromycin Tablets Industry Chain Analysis
7.2 Roxithromycin Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Roxithromycin Tablets Production Mode & Process Analysis
7.4 Roxithromycin Tablets Sales and Marketing
7.4.1 Roxithromycin Tablets Sales Channels
7.4.2 Roxithromycin Tablets Distributors
7.5 Roxithromycin Tablets Customer Analysis
8 Roxithromycin Tablets Market Dynamics
8.1 Roxithromycin Tablets Industry Trends
8.2 Roxithromycin Tablets Market Drivers
8.3 Roxithromycin Tablets Market Challenges
8.4 Roxithromycin Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi-Aventis Deutschland GmbH
Shanghai Shyndec Pharmaceutical Co.,Ltd
Sichuan Kelun Pharmaceutical Co., Ltd.
Chongqing Kerui Pharmaceutical(Group)Co.,Ltd.
Zhejiang Zhenyuan Pharmaceutical Co. Ltd
CSPC Ouyi Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc
Suzhou Dawnrays Pharmaceutical Co., Ltd.
Zhuhai Tongyuan Pharmaceutical Co., Ltd.
Guilin Pharmaceutical Co., Ltd
Jilin Jingxin Pharmaceutical Group Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Tianjin Meihua Pharmaceutical Co., Ltd.
Guangzhou Pui's Pharmaceutical Factory Ltd.
Beijing Chunfeng Pharmaceutical Co., Ltd.
JiLin Daojun Pharmaceutical Co., Ltd.
Liaoning Yifan Pharmaceutical Co., Ltd.
Merro Pharmaceutical Co.,Ltd.
Guangdong Piedy Pharmaceutical Co., Ltd.
Inner Mongolia Northeast LiuYao Group Co., Ltd.
Jiangxi Huiren Pharmaceutical Co., Ltd.
Jiangsu Pengyao Pharmaceuticals, Inc.
Shandong Luyin Pharmaceutical Co., Ltd.
Shaanxi Huaxi Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Roxithromycin Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Roxithromycin Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Roxithromycin Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Roxithromycin Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Roxithromycin Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Roxithromycin Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Roxithromycin Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Roxithromycin Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Roxithromycin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Roxithromycin Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Roxithromycin Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Roxithromycin Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Roxithromycin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Roxithromycin Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Roxithromycin Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Roxithromycin Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Roxithromycin Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Roxithromycin Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Roxithromycin Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Roxithromycin Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Roxithromycin Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Roxithromycin Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Roxithromycin Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Roxithromycin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Roxithromycin Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Roxithromycin Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Roxithromycin Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Roxithromycin Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Roxithromycin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Roxithromycin Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Roxithromycin Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Roxithromycin Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Roxithromycin Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Roxithromycin Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Roxithromycin Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Roxithromycin Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Roxithromycin Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Roxithromycin Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Roxithromycin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Roxithromycin Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Roxithromycin Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Roxithromycin Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Roxithromycin Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Roxithromycin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Roxithromycin Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Roxithromycin Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Roxithromycin Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Roxithromycin Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Roxithromycin Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Roxithromycin Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Roxithromycin Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Roxithromycin Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Roxithromycin Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Roxithromycin Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Roxithromycin Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Roxithromycin Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Roxithromycin Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Roxithromycin Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Roxithromycin Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Roxithromycin Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Roxithromycin Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Roxithromycin Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Roxithromycin Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Roxithromycin Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Roxithromycin Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Roxithromycin Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Roxithromycin Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Roxithromycin Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi-Aventis Deutschland GmbH Company Information
 Table 71. Sanofi-Aventis Deutschland GmbH Description and Business Overview
 Table 72. Sanofi-Aventis Deutschland GmbH Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi-Aventis Deutschland GmbH Roxithromycin Tablets Product
 Table 74. Sanofi-Aventis Deutschland GmbH Recent Developments/Updates
 Table 75. Shanghai Shyndec Pharmaceutical Co.,Ltd. Company Information
 Table 76. Shanghai Shyndec Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 77. Shanghai Shyndec Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Shanghai Shyndec Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product
 Table 79. Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 80. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
 Table 81. Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 82. Sichuan Kelun Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sichuan Kelun Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product
 Table 84. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 85. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
 Table 86. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
 Table 87. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Roxithromycin Tablets Product
 Table 89. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
 Table 90. Jilin Jingxin Pharmaceutical Group Co., Ltd. Company Information
 Table 91. Jilin Jingxin Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 92. Jilin Jingxin Pharmaceutical Group Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Jilin Jingxin Pharmaceutical Group Co., Ltd. Roxithromycin Tablets Product
 Table 94. Jilin Jingxin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 95. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Company Information
 Table 96. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 99. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Hainan Simcere Pharmaceutical Co., Ltd. Company Information
 Table 101. Hainan Simcere Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Hainan Simcere Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hainan Simcere Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 104. Hainan Simcere Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Tianjin Meihua Pharmaceutical Co., Ltd. Company Information
 Table 106. Tianjin Meihua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Tianjin Meihua Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Tianjin Meihua Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 109. Tianjin Meihua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Guangzhou Pui's Pharmaceutical Factory Ltd. Company Information
 Table 111. Guangzhou Pui's Pharmaceutical Factory Ltd. Description and Business Overview
 Table 112. Guangzhou Pui's Pharmaceutical Factory Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Guangzhou Pui's Pharmaceutical Factory Ltd. Roxithromycin Tablets Product
 Table 114. Guangzhou Pui's Pharmaceutical Factory Ltd. Recent Developments/Updates
 Table 115. Beijing Chunfeng Pharmaceutical Co., Ltd. Company Information
 Table 116. Beijing Chunfeng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Beijing Chunfeng Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Beijing Chunfeng Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 119. Beijing Chunfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. CSPC Ouyi Pharmaceutical Co.,Ltd. Company Information
 Table 121. CSPC Ouyi Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 122. CSPC Ouyi Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. CSPC Ouyi Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product
 Table 124. CSPC Ouyi Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 125. JiLin Daojun Pharmaceutical Co., Ltd. Company Information
 Table 126. JiLin Daojun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. JiLin Daojun Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. JiLin Daojun Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 129. JiLin Daojun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Liaoning Yifan Pharmaceutical Co., Ltd. Company Information
 Table 131. Liaoning Yifan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Liaoning Yifan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Liaoning Yifan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 134. Liaoning Yifan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Merro Pharmaceutical Co.,Ltd. Company Information
 Table 136. Merro Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 137. Merro Pharmaceutical Co.,Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Merro Pharmaceutical Co.,Ltd. Roxithromycin Tablets Product
 Table 139. Merro Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 140. Guangdong Piedy Pharmaceutical Co., Ltd. Company Information
 Table 141. Guangdong Piedy Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Guangdong Piedy Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Guangdong Piedy Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 144. Guangdong Piedy Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Inner Mongolia Northeast LiuYao Group Co., Ltd. Company Information
 Table 146. Inner Mongolia Northeast LiuYao Group Co., Ltd. Description and Business Overview
 Table 147. Inner Mongolia Northeast LiuYao Group Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Inner Mongolia Northeast LiuYao Group Co., Ltd. Roxithromycin Tablets Product
 Table 149. Inner Mongolia Northeast LiuYao Group Co., Ltd. Recent Developments/Updates
 Table 150. Livzon Pharmaceutical Group Inc. Company Information
 Table 151. Livzon Pharmaceutical Group Inc. Description and Business Overview
 Table 152. Livzon Pharmaceutical Group Inc. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Livzon Pharmaceutical Group Inc. Roxithromycin Tablets Product
 Table 154. Livzon Pharmaceutical Group Inc. Recent Developments/Updates
 Table 155. Suzhou Dawnrays Pharmaceutical Co., Ltd. Company Information
 Table 156. Suzhou Dawnrays Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Suzhou Dawnrays Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Suzhou Dawnrays Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 159. Suzhou Dawnrays Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
 Table 161. Jiangxi Huiren Pharmaceutical Co., Ltd. Description and Business Overview
 Table 162. Jiangxi Huiren Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Jiangxi Huiren Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 164. Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 165. Zhuhai Tongyuan Pharmaceutical Co., Ltd. Company Information
 Table 166. Zhuhai Tongyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 167. Zhuhai Tongyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Zhuhai Tongyuan Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 169. Zhuhai Tongyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 170. Guilin Pharmaceutical Co., Ltd. Company Information
 Table 171. Guilin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 172. Guilin Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Guilin Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 174. Guilin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 175. Jiangsu Pengyao Pharmaceuticals, Inc. Company Information
 Table 176. Jiangsu Pengyao Pharmaceuticals, Inc. Description and Business Overview
 Table 177. Jiangsu Pengyao Pharmaceuticals, Inc. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Jiangsu Pengyao Pharmaceuticals, Inc. Roxithromycin Tablets Product
 Table 179. Jiangsu Pengyao Pharmaceuticals, Inc. Recent Developments/Updates
 Table 180. Shandong Luyin Pharmaceutical Co., Ltd. Company Information
 Table 181. Shandong Luyin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 182. Shandong Luyin Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Shandong Luyin Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 184. Shandong Luyin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 185. Shaanxi Huaxi Pharmaceutical Co., Ltd. Company Information
 Table 186. Shaanxi Huaxi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 187. Shaanxi Huaxi Pharmaceutical Co., Ltd. Roxithromycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Shaanxi Huaxi Pharmaceutical Co., Ltd. Roxithromycin Tablets Product
 Table 189. Shaanxi Huaxi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Roxithromycin Tablets Distributors List
 Table 193. Roxithromycin Tablets Customers List
 Table 194. Roxithromycin Tablets Market Trends
 Table 195. Roxithromycin Tablets Market Drivers
 Table 196. Roxithromycin Tablets Market Challenges
 Table 197. Roxithromycin Tablets Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Roxithromycin Tablets
 Figure 2. Global Roxithromycin Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Roxithromycin Tablets Market Share by Type: 2024 & 2031
 Figure 4. 50mg Product Picture
 Figure 5. 75mg Product Picture
 Figure 6. 150mg Product Picture
 Figure 7. Global Roxithromycin Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Roxithromycin Tablets Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Roxithromycin Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Roxithromycin Tablets Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Roxithromycin Tablets Sales (2020-2031) & (K Units)
 Figure 16. Global Roxithromycin Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 17. Roxithromycin Tablets Report Years Considered
 Figure 18. Roxithromycin Tablets Sales Share by Manufacturers in 2024
 Figure 19. Global Roxithromycin Tablets Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Roxithromycin Tablets Players: Market Share by Revenue in Roxithromycin Tablets in 2024
 Figure 21. Roxithromycin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Roxithromycin Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Roxithromycin Tablets Sales Market Share by Country (2020-2031)
 Figure 24. North America Roxithromycin Tablets Revenue Market Share by Country (2020-2031)
 Figure 25. United States Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Roxithromycin Tablets Sales Market Share by Country (2020-2031)
 Figure 28. Europe Roxithromycin Tablets Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Roxithromycin Tablets Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Roxithromycin Tablets Revenue Market Share by Region (2020-2031)
 Figure 36. China Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Roxithromycin Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Roxithromycin Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Roxithromycin Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Roxithromycin Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Roxithromycin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Roxithromycin Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Roxithromycin Tablets by Type (2020-2031)
 Figure 55. Global Roxithromycin Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Roxithromycin Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Roxithromycin Tablets by Application (2020-2031)
 Figure 58. Global Roxithromycin Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Roxithromycin Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Roxithromycin Market Insights Forecast to 2030
Global Roxithromycin API Market Research Report 2025
Global Rosithromycin Market Research Report 2024
Global Clarithromycin Market Research Report 2024
Global Moxifloxacin Hydrochloride Tablets Market Research Report 2024
Global Clarithromycin Tablets Market Insights Forecast to 2030
Global Azithromycin Market Insights Forecast to 2030
Global Josamycin Tablets Market Research Report 2024
Global Acetylspiramycin Tablet Market Research Report 2024
Global Erythromycin Market Insights Forecast to 2030
Global Amoxicillin Capsule Market Insights Forecast to 2030
Global Erythromycin Thiocyanate Market Research Report 2024
Global Tulathromycin Market Research Report 2024
Global Amoxicillin Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Amoxicillin Antibiotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Norfloxacin Tablets Market Research Report 2025
Global Azithromycin Injection Market Research Report 2024
Global Minocycline Hydrochloride Capsules Market Research Report 2024
Global Andrographolide Tablets Market Research Report 2024
Global Levofloxacin Tablets Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions